$8.87
arrow_drop_down1.49%Key Stats | |
---|---|
Open | $8.98 |
Prev. Close | $9.01 |
EPS | 1.16 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $43.10M |
LOW | HIGH | |
---|---|---|
Day Range | 8.78 | 8.99 |
52 Week Range | 7.11 | 10.04 |
Ratios | |
---|---|
EBITDA Margin % | - |
EPS | 1.16 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
Daxor Corporation Awarded New U.S. Defense Health Agency - GlobeNewswire
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024